Table 2.
Group
|
TBIL (μmol/L)
|
ALT (U/L)
|
AST (U/L)
|
Cr (μmol/L)
|
GFR (mL/min)
|
Control group (n = 26) | |||||
Before treatment | 43.4 ± 20.97a | 42.35 ± 4.55a | 40.29 ± 9.16 | 78.54 ± 15.67 | 97.28 ± 23.06 |
After treatment | 23.43 ± 5.28 | 35.96 ± 3.66 | 39.88 ± 8.54 | 85.46 ± 12.67 | 102.87 ± 30.24 |
Treatment group (n = 28) | |||||
Before treatment | 38.92 ± 5.04 | 46.75 ± 7.43 | 43.11 ± 7.28 | 77.89 ± 15.38 | 92.45 ± 20.33 |
After treatment | 38.26 ± 9.16 | 41.13 ± 8.75 | 42.54 ± 10.01 | 72.34 ± 16,43 | 98.29 ± 18.98 |
P < 0.05, compared with before treatment.
TBIL: Total bilirubin; ALT: Alanine transaminase; AST: Aspartate aminotransferase; Cr: Creatinine; GFR: Glomerular filtration rate.